Decisions in patent ownership disputes are rare in Spain. The last significant one was the 2022 judgment from the Spanish Supreme Court in the “Ecoforest” case. Now, the Valencia Court of Appeal – a growing forum for patent disputes – rules that the two-year statute of limitations for filing patent ownership claims cannot be interrupted….
Brazil’s long-running effort to internalize drug manufacture through state-backed technology transfer agreements continues to face scrutiny. On May 7, 2025, the country’s Government Accountability Office (GAO) upheld its prior recommendation that the Ministry of Health (MOH) refrain from initiating new Partnerships for Productive Development (Parcerias para o Desenvolvimento Produtivo – PDPs) until it can demonstrate…
The Brazilian Patent and Trademark Office (BRPTO) published Ordinance No. 04/2025 (May 27, 2025), which formalizes the internal workflow for resuming the technical examination of patent applications following an appeal against a previous rejection decision (identified by publication code 100.2). The ordinance consolidates and standardizes the procedures to be followed when the BRPTO’s Board of…
On 14 May, the EPO published the study Standards and the European patent system. The study seeks to improve transparency in the relationship between standards and patents in Europe, by providing insights from an EPO dataset linking patents and standards. The study also provides early observations into SEP litigation under the UPC. I will very…
As spring turns to summer and the days grow longer across EPC Member States (and, in some cases, banish darkness entirely with the midnight sun!), many of us in the IP community eagerly await the release of the new Visser, now in its 33rd iteration! As always, this version includes numerous updates reflecting changes in…
ANVISA (the Brazilian regulatory authority) is considering updating rules addressing medical devices in a clear indication that this market is growing and requires more attention. Medical devices play a vital role in healthcare, having evolved from simple tools like thermometers and bandages to sophisticated technologies such as robotic surgical systems, implantable neurostimulators, and AI-powered diagnostics….
The Court of Appeal’s judgment in Optis Cellular Technology LLC v Apple Retail UK Ltd [2025] EWCA Civ 552, handed down on 1 May 2025, is arguably the most significant UK FRAND decision since Unwired Planet v Huawei. It not only overturns the High Court’s FRAND determination but re-establishes the centrality of a comparables-based approach…
*Also co-authored by Tatiana Costa Vaccination plays a crucial role in the prevention of diseases caused by etiological agents. The origins of vaccines trace back to the late 18th century, when Edward Jenner demonstrated the effectiveness of using cowpox as an immunizing agent against smallpox. Vaccines have made an undeniable contribution to public health by…
As patent aficionados are well aware, after the European Patent Office (“EPO”) published Decision G 0002/21, there was widespread expectation across Europe regarding whether or not the few national courts that require some sort of “plausibility” as a precondition for inventive step and/or sufficiency, would adapt their case law to the test introduced by G…
Article 9(4) of Directive 2004/48/EC obliges Member States to ensure that courts may issue provisional measures, including injunctions, without giving prior notice to the defendant in certain circumstances. This applies, in particular, when a delay is likely to result in irreparable harm to the rights holder, or when there may be a real risk that…
